Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
Crossref DOI link: https://doi.org/10.1186/s41232-016-0017-2
Published Online: 2016-06-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Imai, Toshio
Yasuda, Nobuyuki
